Randomized, Controlled Study Evaluating CERE-110 in Subjects With Mild to Moderate Alzheimer's Disease
Clinical trial NCT00876863 · COMPLETED
Trial details
- NCT number
- NCT00876863
- Sponsor
- Sangamo Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-11-01
- Primary completion
- 2015-08-13
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.